RE:If they split, Apparo will die, Viemed will thriveLOL... new handle, typical basher spew, but could only sound credible by first admitting Viemed is doing really well.
Did you get clearance from basher boss first? Might have shortened your boiler room career.
jomen1789 wrote:
Sleep Management aka Viemed is doing great. Hiring employees, getting ORGANIC growth, big profits.
PHM told us in November that good profits were coming. That's only partly true. I believe the Viemed part delivered, but the Apparo part had an ABYSMAL performance. They are really holding down PHM so much that not even Viemed's excellent growth could offset Apparo's failures.
I think this split is really about jettisoning Apparo, and keeping the good part separated, so Viemed can rise.
All that "cross selling will be good for PHM's disparate companies", that was a load of hogwash by Dalsin. It's apparent that someone who suffers from breathing problems may not necessarily suffer from muscle disease, so the cross selling doesn't work, which is why they separated and NOT ONE WORD ON CROSS-SELLING HELPING OUT THE COMPANY.
My average is only $0.25 so I can surely get afloat in 2 quarters. But for people with $1.00 average, don't count on Apparo's doubling your shares to help out. Only Viemed can carry this dysfunctional team.
Apparo is cutting the bad account receivables in chunks, just cutting off enough per quarter to say "hey we still have more assets than debts". I bet that scumbag Dalsin and his former CFO (who also ruined Convalo) were going "just sell your products to people with bad credit as much as you can, that will boost account receivable and our assets value"
Hoyt and Crawford are competent administrators, but they inherited multiple bad companies (outside of Sleep Management and Patient Aids, the other divisions of PHM are terrible), and they have to fix the filthy mess left by Dalsin and Greene.
You guys at $1.00 average:
-Pray that Trump proves to be an enlightened President that thinks outside the box and will fund home health care. Would be huge for both Apparo and Viemed.
-That the 20% reimbursement bill on ventilators passes ( this will mostly benefit Viemed). The sponsor of that bill is a Republican, might improve the chance of that passing, but again we don't know what Trump will do. He seems more about reforming than just throw money here and there without reason.
Viemed I will keep long term, but Apparo? UGH